1256
W. Fan et al.
Letter
Synlett
Supporting Information
(9) Shang, Y.-P.; Jie, X.-M.; Zhou, J.; Hu, P.; Huang, S.-J.; Su, W.-P.
Angew. Chem. Int. Ed. 2013, 52, 1299.
Supporting information for this article is available online at
(10) For the reactions that involve dehydrogenation to olefins fol-
lowed by a coupling process, see: (a) Terao, Y.; Kametani, Y.;
Wakui, H.; Satoh, T.; Miura, M.; Nomura, M. Tetrahedron 2001,
57, 5967. (b) Ueno, S.; Shimizu, R.; Kuwano, R. Angew. Chem. Int.
Ed. 2009, 48, 4543. (c) Stang, E. M.; White, M. C. J. Am. Chem. Soc.
2011, 133, 14892. (d) Leskinen, M. V.; Yip, K.-T.; Valkonen, A.;
Pihko, P. M. J. Am. Chem. Soc. 2012, 134, 5750. (e) Moon, Y.;
Kwon, D.; Hong, S. Angew. Chem. Int. Ed. 2012, 51, 11333.
(11) (a) Reichwald, C.; Shimony, O.; Sacerdoti-Sierra, N.; Jaffe, C. L.;
Kunick, C. Bioorg. Med. Chem. Lett. 2008, 18, 1985.
(b) Reichwald, C.; Shimony, O.; Dunkel, U.; Sacerdoti-Sierra, N.;
Jaffe, C. L.; Kunick, C. J. Med. Chem. 2008, 51, 659.
(12) Zhang, X.-G.; Fan, S.-L.; He, C.-Y.; Wan, X.-L.; Min, Q.-Q.; Yang, J.;
Jiang, Z.-X. J. Am. Chem. Soc. 2010, 132, 4506.
(13) Pennell, M. N.; Sheppard, T. D.; Unthank, M. S.; Turner, P. J. Org.
Chem. 2011, 76, 1479.
(14) Musumarra, G.; Ballistreri, F. P. Org. Magn. Reson. 1980, 14, 384.
(15) Mori, A.; Miyakawa, Y.; Ohashi, E.; Haga, T.; Maegawa, T.; Sajiki,
H. Org. Lett. 2006, 8, 3279.
(16) Ranu, B. C.; Jana, R. J. Org. Chem. 2005, 70, 8621.
(17) Liu, D.-N.; Tian, S.-K. Chem. Eur. J. 2009, 15, 4538.
(18) Synthesis of 3a–p
S
u
p
p
ortioInfgrmoaitn
S
u
p
p
ortiInfogrmoaitn
References and Notes
(1) The authors contributed equally to this work.
(2) For a review on the bioactivity of chalcones, see: Dimmock, J. R.;
Elias, D. W.; Beazely, M. A.; Kandepu, N. M. Curr. Med. Chem.
1999, 6, 1125.
(3) (a) Konieczny, M. T.; Konieczny, W.; Sabisz, M.; Skladanowski,
A.; Wakiec, R. J. Med. Chem. 2007, 42, 729. (b) Kumar, D.; Kumar,
N. M.; Akamatsu, K.; Kusaka, E.; Harada, H.; Ito, T. Bioorg. Med.
Chem. Lett. 2010, 20, 3916. (c) Ducki, S.; Forrest, R.; Hadfield, J.
A.; Kendall, A.; Lawrence, N. J.; McGown, A. T.; Rennison, D.
Bioorg. Med. Chem. Lett. 1998, 8, 1051. (d) Edenharder, R.;
Petersdorff, I. V.; Rauscher, R. Mutat. Res. 1993, 287, 261.
(e) Pandeya, S. N.; Sriram, D.; Nath, G.; DeClercq, E. Eur. J. Med.
Chem. 1999, 9, 25. (f) Buolamwini, J. K.; Assefa, H. J. Med. Chem.
2002, 45, 841. (g) Nowakowska, Z. Eur. J. Med. Chem. 2007, 42,
125. (h) Ram, V. J.; Saxena, A. S.; Srivastava, S.; Chandra, S.
Bioorg. Med. Chem. Lett. 2000, 10, 2159.
(4) For selected examples of the syntheses of organic functional
materials from chalcones, see: (a) Ribierre, J.-C.; Cheval, G.;
Huber, F.; Mager, L.; Fort, A.; Muller, R.; Mery, S.; Nicoud, J. F. J.
Appl. Phys. 2002, 91, 1710. (b) Melzer, C.; Barzoukas, M.; Fort,
A.; Mery, S.; Nicoud, J.-C. Appl. Phys. Lett. 1997, 71, 2248.
(5) Thebtaranonth, C.; Thebtaranonth, Y. In The Chemistry of
Enones; Vol. 29; Patai, S.; Rappoport, Z., Eds.; Wiley: New York,
1989, 199.
(6) (a) Müller, T. J. J.; Ansorge, M.; Aktah, D. Angew. Chem. Int. Ed.
2000, 39, 1253. (b) Braun, R. U.; Ansorge, M.; Müller, T. J. J.
Chem. Eur. J. 2006, 12, 9081. (c) Wu, X.-F.; Neumann, H.; Beller,
M. Angew. Chem. Int. Ed. 2010, 49, 5284. (d) Wu, X.-F.;
Neumann, H.; Spannenberg, A.; Schulz, T.; Jiao, H.; Beller, M. J.
Am. Chem. Soc. 2010, 132, 14596.
A mixture of 1 (0.2 mmol), 2 (0.6 mmol), DMSO (3 mL),
Pd(OAc)2 (5 mol%), and Ag2CO3 and Ag2O (1.5 equiv, 1:1) was
stirred at 120 °C under air atmosphere for 24 h. To the reaction
mixture was added H2O and EtOAc, and the aqueous phase was
extracted with EtOAc (3×). The combined organic layer was
washed with brine, dried over Na2SO4, and evaporated under
reduced pressure. The crude product was purified by silica gel
column chromatography to give the corresponding products
(3a,12 3g,13 3h,14 3i–l,9 3m,16 3n,17 3p,q,s–v9 according to the lit-
erature).
(E)-3-(2,3,4,6-Tetrafluorophenyl)-1-phenylprop-2-en-1-one
(3b)
Yield 74%. 1H NMR (500 MHz, CDCl3): δ = 7.85 (d, J = 7.2 Hz, 2
H), 7.78–7.50 (m, 4 H), 7.35 (d, J = 16.8 Hz, 1 H), 7.08 (m, 1 H).
13C NMR (125 MHz, CDCl3): δ = 190.2, 153.0 (dm, J = 248.0 Hz),
149.9 (dm, J = 251.0 Hz), 148.5 (dm, J = 249.6 Hz), 139.2 (dm,
J = 241.2 Hz), 136.8, 135.9 (m), 131.5, 128.6, 126,9, 115.8, 114.1
(m), 102.9 (m). 19F NMR (282 MHz, CDCl3): δ = –118.5 (t, J = 9.6
Hz, 1 F), –134.9 (m, 1 F), –138.7 (dd, J = 19.5, 5.5 Hz, 1 F), –163.8
(m, 1 F). HRMS: m/z calcd for C15H8OF4: 280.0511; found:
280.0517.
(7) (a) Wang, D.; Zhang, Y.; Harris, A.; Gautam, L. N. S.; Chen, Y.; Shi,
X.-D. Adv. Synth. Catal. 2011, 353, 2584. (b) Albaladejo, M. J.;
Alonso, F.; Yus, M. Chem. Eur. J. 2013, 19, 5242. (c) Bukhari, S. N.
A.; Jasamai, M.; Jantan, I.; Ahmad, W. Mini-Rev. Org. Chem. 2013,
10, 73.
(8) For selected books and reviews, see: (a) C–HActivation, In Topics
in Current Chemistry; Vol. 292; Yu, J.-Q.; Shi, Z.-J., Eds.; Springer:
Berlin, 2010. (b) Kakiuchi, F.; Chatani, N. Adv. Synth. Catal. 2003,
345, 1077. (c) Satoh, T.; Miura, M. Chem. Lett. 2007, 36, 200.
(d) Chen, X.; Engle, K. M.; Wang, D.-H.; Yu, J.-Q. Angew. Chem.
Int. Ed. 2009, 48, 5094. (e) Li, C.-J. Acc. Chem. Res. 2009, 42, 335.
(f) Daugulis, O.; Do, H.-D.; Shabashov, D. Acc. Chem. Res. 2009,
42, 1074. (g) Ackermann, L.; Vicente, R.; Kapdi, A. R. Angew.
Chem. Int. Ed. 2009, 48, 9792. (h) Lyons, T. W.; Sanford, M. S.
Chem. Rev. 2010, 110, 1147. (i) Yeung, C. S.; Dong, V. M. Chem.
Rev. 2011, 111, 1215. (j) Bugaut, X.; Glorius, F. Angew. Chem. Int.
Ed. 2011, 50, 7479. (k) Liu, C.; Zhang, H.; Shi, W.; Lei, A. Chem.
Rev. 2011, 111, 1780. (l) Wencel-Delord, J.; Droge, T.; Liu, F.;
Glorius, F. Chem. Soc. Rev. 2011, 40, 4740. (m) Colby, D. A.;
Bergman, R. G.; Ellman, J. A. Chem. Rev. 2010, 110, 624.
(n) Engle, K. M.; Mei, T.-S.; Wasa, M.; Yu, J.-Q. Acc. Chem. Res.
2012, 45, 788. (o) Brückl, T.; Baxter, R. D.; Ishihara, Y.; Baran, P.
S. Acc. Chem. Res. 2012, 45, 826.
(E)-3-(2,4,6-Trifluorophenyl)-1-phenylprop-2-en-1-one (3c)
Yield 71%. 1H NMR (500 MHz, CDCl3): δ = 7.84 (d, J = 7.0 Hz, 2
H), 7.62–7.50 (m, 4 H), 7.34 (d, J = 16.6 Hz, 1 H), 6.96 (t, J = 9.0
Hz, 2 H). 13C NMR (125 MHz, CDCl3): δ = 189.8, 165.2 (dm,
J = 248.8 Hz), 139.1, 135.8 (m), 130.5, 128.9, 127.8, 117.1, 111.9
(m), 101.9 (m). 19F NMR (282 MHz, CDCl3): δ = –105.7 (m, 1 F), –
113.1 (t, J = 8.2 Hz, 2 F). HRMS: m/z calcd for C15H9OF3:
262.0605; found: 262.0613.
(E)-3-(2,3,5,6-Tetrafluorophenyl)-1-phenylprop-2-en-1-one
(3d)
1
Yield 79%. H NMR (500 MHz, CDCl3): δ = 7.837–7.75 (m, 3 H),
7.68–7.59 (m, 3 H), 7.35 (d, J = 17.4 Hz, 1 H), 7.15 (m, 1 H). 13C
NMR (125 MHz, CDCl3): δ = 190.3, 149.5 (dm, J = 256.4 Hz),
145.8 (dm, J = 262.5 Hz), 138.7 (m), 137.1, 128.5, 127.6, 118.3
(m), 114.5, 103.6 (t, J = 22.8 Hz). 19F NMR (282 MHz, CDCl3): δ =
–139.7 (m, 2 F), –144.8 (m, 2 F). HRMS: m/z calcd for C15H8OF4:
280.0511; found: 280.0508.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2015, 26, 1253–1257